Vaccines for Children 2024-2025
Closed Solicitation Posted
- Solicitation number
- 75D30123Q77360
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation requests offers for indefinite delivery, indefinite quantity contracts to purchase a total of 27 pediatric vaccines for the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases. Minimum and maximum order quantities are specified for each vaccine, which must meet a 12-month minimum shelf life and be licensed by the FDA. Offers are due by February 9, 2024 and must include pricing, past performance references, and agree to packaging, delivery, invoicing and EDI terms. The period of performance is from April 1, 2024 through March 31, 2025. Questions regarding this solicitation must be submitted in writing by February 2, 2024.
There is no set-aside designated. The solicitation seeks to procure between 100 doses and 13 million doses of each pediatric vaccine for a total period of performance of April 1, 2024 through March 31, 2025. Vaccines will be shipped F.O.B. destination to the 50 states and U.S. territories to support the CDC's Immunization Awardees program and Vaccines for Children program. The place of performance will be within the United States.
Notice text
2 versions
Update #2 · Latest ·
UPDATE 02/05/2024: The answers to the vendor questions received by the question deadline have been attached to this posting.
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following pediatric vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration:
Dengue vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 50K Doses
Minimum: 100 Doses
DTaP vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 6.5M Doses
Minimum: 100 Doses
DTaP/Hep B/IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.75 per dose
Maximum: 5.38M Doses
Minimum: 100 Doses
DTaP-IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.00 per dose
Maximum: 3.5M Doses
Minimum: 100 Doses
DTaP-IP-HIB vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.75 per dose
Maximum: 7.5M Doses
Minimum: 100 Doses
DTaP-IPV-HIB-HEPB vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $4.50 per dose
Maximum: 3M Doses
Minimum: 100 Doses
E-IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 4M Doses
Minimum: 100 Doses
Hepatitis A (pediatric) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 8.5M Doses
Minimum: 100 Doses
Hepatitis A&B (Age 18 only) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100K Doses
Minimum: 100 Doses
Hepatitis B (pediatric/adol.) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 7.7M Doses
Minimum: 100 Doses
Hib vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 8M Doses
Minimum: 100 Doses
Human Papillomavirus vaccine, Recombinant
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 9M Doses
Minimum: 100 Doses
Measles, Mumps & Rubella (MMR) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 8M Doses
Minimum: 100 Doses
Meningococcal Conjugate (MCV4) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 6.5M Doses
Minimum: 100 Doses
Meningococcal Conjugate- Serogroup B Meningococcal vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 750K Doses
Minimum: 100 Doses
Mpox vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: TBD
Maximum: 125K Doses
Minimum: 100 Doses
Pneumococcal Conjugate vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 13M Doses
Minimum: 100 Doses
Pneumococcal (23 Valent) Polysaccharide vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 350K Doses
Minimum: 100 Doses
Rotavirus vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 7M Doses
Minimum: 100 Doses
Respiratory Syncytial Virus vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: TBD
Maximum: 2.5M Doses
Minimum: 100 Doses
Tetanus and Diphtheria (Td) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 750K Doses
Minimum: 100 Doses
Tdap vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 5.5M Doses
Minimum: 100 Doses
Varicella vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 10M Doses
Minimum: 10 Doses
Measles, Mumps & Rubella and Varicella (MMR-V) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.00 per dose
Maximum: 3.4M Doses
Minimum: 10 Doses
Serogroup B Meningococcal vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 2.5M Doses
Minimum: 100 Doses
The vaccines awarded under these contracts will be purchased for and by NCIRD's Immunization Awardees to support pediatric immunization programs as provided under Section 317(j) of the Public Health Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items. Vaccines shall be shipped F.O.B. Destination to the 50
states and U.S. Territories.
The period of performance shall be 4/1/2024 – 3/31/2025.
Any questions regarding this notice shall be submitted in writing to William O'Bryan at rvq0@cdc.gov by 5:00 PM Eastern Time on February 2, 2024. Telephone inquiries will not be honored.
Update #1 ·
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following pediatric vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration:
Dengue vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 50K Doses
Minimum: 100 Doses
DTaP vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 6.5M Doses
Minimum: 100 Doses
DTaP/Hep B/IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.75 per dose
Maximum: 5.38M Doses
Minimum: 100 Doses
DTaP-IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.00 per dose
Maximum: 3.5M Doses
Minimum: 100 Doses
DTaP-IP-HIB vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.75 per dose
Maximum: 7.5M Doses
Minimum: 100 Doses
DTaP-IPV-HIB-HEPB vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $4.50 per dose
Maximum: 3M Doses
Minimum: 100 Doses
E-IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 4M Doses
Minimum: 100 Doses
Hepatitis A (pediatric) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 8.5M Doses
Minimum: 100 Doses
Hepatitis A&B (Age 18 only) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100K Doses
Minimum: 100 Doses
Hepatitis B (pediatric/adol.) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 7.7M Doses
Minimum: 100 Doses
Hib vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 8M Doses
Minimum: 100 Doses
Human Papillomavirus vaccine, Recombinant
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 9M Doses
Minimum: 100 Doses
Measles, Mumps & Rubella (MMR) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 8M Doses
Minimum: 100 Doses
Meningococcal Conjugate (MCV4) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 6.5M Doses
Minimum: 100 Doses
Meningococcal Conjugate- Serogroup B Meningococcal vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 750K Doses
Minimum: 100 Doses
Mpox vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: TBD
Maximum: 125K Doses
Minimum: 100 Doses
Pneumococcal Conjugate vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 13M Doses
Minimum: 100 Doses
Pneumococcal (23 Valent) Polysaccharide vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 350K Doses
Minimum: 100 Doses
Rotavirus vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 7M Doses
Minimum: 100 Doses
Respiratory Syncytial Virus vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: TBD
Maximum: 2.5M Doses
Minimum: 100 Doses
Tetanus and Diphtheria (Td) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 750K Doses
Minimum: 100 Doses
Tdap vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 5.5M Doses
Minimum: 100 Doses
Varicella vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 10M Doses
Minimum: 10 Doses
Measles, Mumps & Rubella and Varicella (MMR-V) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.00 per dose
Maximum: 3.4M Doses
Minimum: 10 Doses
Serogroup B Meningococcal vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 2.5M Doses
Minimum: 100 Doses
The vaccines awarded under these contracts will be purchased for and by NCIRD's Immunization Awardees to support pediatric immunization programs as provided under Section 317(j) of the Public Health Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items. Vaccines shall be shipped F.O.B. Destination to the 50
states and U.S. Territories.
The period of performance shall be 4/1/2024 – 3/31/2025.
Any questions regarding this notice shall be submitted in writing to William O'Bryan at rvq0@cdc.gov by 5:00 PM Eastern Time on February 2, 2024. Telephone inquiries will not be honored.
Files
| File | Type | Posted |
|---|---|---|
| Questions and Answers RFQ 75D301-23-Q-77360.xlsx | XLSX spreadsheet | |
| A19 - Solicitation 75D301-23-Q-77360.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity